Optimizing Multidisciplinary Care of Patients with Hidradenitis Suppurativa
Vivian Shi, MD, FAAD, offers clinical insights on best practices for optimizing multidisciplinary care of patients with hidradenitis suppurativa.
The Role of Surgery in Hidradenitis Suppurativa
Dr. Shi provides insights on patients with hidradenitis suppurativa for whom surgical intervention would be an appropriate treatment modality.
Managing Pain in Patients with Hidradenitis Suppurativa
A dermatologist provides clinical insights on managing pain in patients with hidradenitis suppurativa.
Ongoing Research in Hidradenitis Suppurativa
An expert on hidradenitis suppurativa gives an overview of the current research landscape, highlighting exciting developments in the treatment space.
Recent Data on Bimekizumab for Hidradenitis Suppurativa
Vivian Shi, MD, FAAD, reviews recent phase 3 data on bimekizumab, a biologic therapy for patients with hidradenitis suppurativa.
Biologic Therapies for Hidradenitis Suppurativa
A dermatologist outlines the role for biologic therapies in the hidradenitis suppurativa treatment landscape and discusses the importance of early intervention.
The Role of Treatment Guidelines for HS
Vivian Shi, MD, FAAD, provides an overview of current treatment guidelines for hidradenitis suppurativa and discusses ways to improve upon them.
Hidradenitis Suppurativa (HS): Staging Considerations and Unmet Needs
An expert on hidradenitis suppurativa (HS) provides an overview of the Hurley staging system and discusses unmet needs in the overall treatment landscape.
